GCG and osteoarthritis: There are consistent signals across limited pre-clinical and human studies to support the potential favourable structural protective, immunomodulatory and analgesic effects of GLP-1 agonists in osteoarthritis, irrespective of the quality and heterogeneity of the included studies.